SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Valtteri Kaasinen, Maija Kinos, Juho Joutsa, Marko Seppänen, Tommi Noponen, Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson’s disease, European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41, 10, 1931

    CrossRef

  2. 2
    Lyndsey E. Collins-Praino, Nicholas E. Paul, Felicia Ledgard, Samantha J. Podurgiel, Rotem Kovner, Younis Baqi, Christa E. Müller, Patrick B. Senatus, John D. Salamone, Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism, European Journal of Neuroscience, 2013, 38, 1
  3. 3
    M. Verdal, D. Renard, L. Collombier, V. Boudousq, P. O. Kotzki, P. Labauge, G. Castelnovo, I123-FP-CIT single-photon emission tomography in patients with long-standing mixed tremor, European Journal of Neurology, 2013, 20, 2
  4. 4
    Marianna Selikhova, Peter A. Kempster, Tamas Revesz, Janice L. Holton, Andrew J. Lees, Neuropathological findings in benign tremulous Parkinsonism, Movement Disorders, 2013, 28, 2
  5. 5
    Anthony E. Lang, Eldad Melamed, Werner Poewe, Olivier Rascol, Trial designs used to study neuroprotective therapy in Parkinson's disease, Movement Disorders, 2013, 28, 1
  6. 6
    Francisco Coria, Marta Gimenez-Garcia, Lluis Samaranch, Francisco J. Mora, Catalina Sampol-Bas, Pau Pastor, Nigrostriatal dopaminergic function in subjects with isolated action tremor, Parkinsonism & Related Disorders, 2012, 18, 1, 49

    CrossRef

  7. 7
    Niall P. Quinn, Susanne A. Schneider, Petra Schwingenschuh, Kailash P. Bhatia, Tremor—some controversial aspects, Movement Disorders, 2011, 26, 1
  8. 8
    Mark J. Millan, From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease, Pharmacology & Therapeutics, 2010, 128, 2, 229

    CrossRef

  9. 9
    Karen Nuytemans, Jessie Theuns, Marc Cruts, Christine Van Broeckhoven, Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update, Human Mutation, 2010, 31, 7
  10. 10
    Donald L. Bliwise, Lynn Marie Trotti, Sophia A. Greer, Jorge J. Juncos, David B. Rye, Phasic muscle activity in sleep and clinical features of Parkinson disease, Annals of Neurology, 2010, 68, 3
  11. 11
    S. Paus, F. Gadow, O. Kaut, M. Knapp, C. Klein, T. Klockgether, U. Wüllner, Tremor in Parkinson’s disease is not associated with the DRD3 Ser9Gly polymorphism, Parkinsonism & Related Disorders, 2010, 16, 6, 381

    CrossRef

  12. 12
    K. Ray Chaudhuri, Per Odin, Recent Advances in Parkinson’S Disease - Translational and Clinical Research, 2010,

    CrossRef

  13. 13
    M. Selikhova, D. R. Williams, P. A. Kempster, J. L. Holton, T. Revesz, A. J. Lees, A clinico-pathological study of subtypes in Parkinson's disease, Brain, 2009, 132, 11, 2947

    CrossRef

  14. 14
    Giovanni Rizzo, Sara Marconi, Sabina Capellari, Cesa Scaglione, Paolo Martinelli, Benign tremulous parkinsonism in a patient with dardarin mutation, Movement Disorders, 2009, 24, 9
  15. You have free access to this content15
    Payal N. Gandhi, Shu G. Chen, Amy L. Wilson-Delfosse, Leucine-rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease, Journal of Neuroscience Research, 2009, 87, 6
  16. 16
    Coro Paisán-Ruiz, LRRK2 gene variation and its contribution to Parkinson disease, Human Mutation, 2009, 30, 8
  17. 17
    K. Ray Chaudhuri, Yogini Naidu, Early Parkinson’s disease and non-motor issues, Journal of Neurology, 2008, 255, S5, 33

    CrossRef

  18. 18
    S. N. Pchelina, A. F. Yakimovskii, A. K. Emelyanov, O. N. Ivanova, A. L. Schwarzman, A. B. Singleton, Screening for LRRK2 mutations in patients with Parkinson’s disease in Russia: identification of a novel LRRK2 variant, European Journal of Neurology, 2008, 15, 7